EdgeLeap is an information technology company pushing AI to its limits to surface business relevant insights from continuous stream of world’s information, helping their clients can make intelligent strategic decisions every day.

Firbornectin-EDA Monoclonal antibody for the prevention of chronic heart failure

Encytos has developed a micro(nano)structured (topographic) inorganic substrate for spheroid and organoid cell growth.

Simple blood tests to detect cancer

Opposed to the current heparin production method, our technology has the potential to ensure supply security, reduce risk of contamination and remove dependency on animal material.

We created a method of projecting a surgical planning onto the patient. This way the surgeon spends less time on preparation (20 min) and performs surgeries faster (19 min). The prototype is in continuous use in Radboudumc (400+ surgeries).

Optimal delivery to ensure effective treatment of cancer and more

Fenix Therapeutics aims to reshape cancer outcomes, providing hope to patients by transforming the future of oncology through more specific and effective treatments.

Personalized targeted treatment selection for metastatic cancer patients through full blood volume tumor cell analysis.

Gateway Bio solves antimicrobial resistance. Our proprietary nanocarrier transports antibiotic payloads inside bacterial cells, bypassing resistance mechanisms. The platform is compound-agnostic, compatible with existing and pipeline antibiotics, and its modular design enables partners to generate patent protection across successive lifecycle stages. Our proprietary production process ensures scalability at low cost, a critical differentiator in this market.